EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeit

Safety and Efficacy of Anti-OX40 Therapies in Atopic Dermatitis: A Systematic Review and Meta-Analysis

Helen Michaela de Oliveira iD, Mariano Gallo Ruelas, Camilo André Viana Diaz, Laura Ghanem, Lilia Maria Lima de Oliveira

Dermatitis® · 01.03.2026 · 37 (2) · 195-204

DOI: 10.1089/derm.2025.0057 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Dermatitis®, online erschienen am 14.04.2025. Verfasst von Helen Michaela de Oliveira und 4 weiteren Autor:innen. Beteiligte Einrichtung: From the, Department of Medicine, Federal University of Mato Grosso, Sinop, Brazil. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Receptors, OX40. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic inflammatory skin disorder that significantly impacts patients’ quality of life. Novel biological agents targeting the OX40 pathway have shown promise in refractory cases. We aimed to systematically evaluate the efficacy and safety of anti-OX40 therapies (amlitelimab, rocatinlimab, and telazorlimab) in moderate-to-severe AD. We systematically searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) databases up to January 2025 for clinical trials comparing anti-OX40 therapies with placebo in patients with AD. This study followed Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Five randomized clinical trials were included, comprising 1118 patients, of whom 857 (76.6%) received one of the anti-OX40 therapies. Both high-dose (mean difference [MD] = −17.33; 95% confidence interval [CI] = −23.79 to −10.87; P < 0.001) and low-dose (MD = −16.35; 95% CI = −27.42 to −5.28; P = 0.004) regimens significantly improved the SCORing AD, and multiple other outcomes also showed statistically significant improvements, including reductions in the mean Eczema Area and Severity Index score and body surface area affected by the disease. The incidence of any treatment-emergent adverse event was not statistically significant for either the high-dose group (risk ratio [RR] = 1.14; 95% CI = 0.82–1.59; P = 0.443) or the low-dose group (RR = 1.10; 95% CI = 0.84–1.45; P = 0.486). In conclusion, anti-OX40 therapies demonstrate clinically meaningful efficacy and an acceptable safety profile for moderate-to-severe AD, offering a potential alternative for patients with inadequate responses to current treatments. Further research is warranted to confirm these results and to refine optimal dosing strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicReceptors, OX40HumansRandomized Controlled Trials as TopicAntibodies, Monoclonal, Humanized

Substanzen

Receptors, OX40Antibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • From the, Department of Medicine, Federal University of Mato Grosso, Sinop, Brazil.
  • Instituto de Investigación Nutricional, Lima, Peru.
  • Department of Medicine, Federal University of Triângulo Mineiro, Uberaba, Brazil.
  • Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
  • Teaching Assistant II-Post-graduate Program, Harvard T.H. Chan School of Public Health, Principles and Practice of Clinical Research, ECPE, Boston, Massachusetts, USA.

ORCID-Profile: Helen Michaela de Oliveira

Zitieren

APA

de Oliveira, H. M., Gallo Ruelas, M., Viana Diaz, C. A., Ghanem, L., & Lima de Oliveira, L. M. (2026). Safety and Efficacy of Anti-OX40 Therapies in Atopic Dermatitis: A Systematic Review and Meta-Analysis. Dermatitis®, 37(2), 195-204. https://doi.org/10.1089/derm.2025.0057

Vancouver

de Oliveira HM, Gallo Ruelas M, Viana Diaz CA, Ghanem L, Lima de Oliveira LM. Safety and Efficacy of Anti-OX40 Therapies in Atopic Dermatitis: A Systematic Review and Meta-Analysis. Dermatitis®. 2026;37(2):195-204. doi:10.1089/derm.2025.0057

BibTeX
@article{deOliveira2026,
  author = {de Oliveira, Helen Michaela and Gallo Ruelas, Mariano and Viana Diaz, Camilo André and Ghanem, Laura and Lima de Oliveira, Lilia Maria},
  title = {Safety and Efficacy of Anti-OX40 Therapies in Atopic Dermatitis: A Systematic Review and Meta-Analysis},
  journal = {Dermatitis®},
  year = {2026},
  volume = {37},
  number = {2},
  pages = {195--204},
  doi = {10.1089/derm.2025.0057}
}
Kostenlos starten →